These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. HMG-CoA reductase inhibitor enhances inducible nitric oxide synthase expression in rat vascular smooth muscle cells; involvement of the Rho/Rho kinase pathway. Yamamoto T; Takeda K; Harada S; Nakata T; Azuma A; Sasaki S; Nakagawa M Atherosclerosis; 2003 Feb; 166(2):213-22. PubMed ID: 12535733 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of geranylgeranylation mediates the effects of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors on microglia. Bi X; Baudry M; Liu J; Yao Y; Fu L; Brucher F; Lynch G J Biol Chem; 2004 Nov; 279(46):48238-45. PubMed ID: 15364922 [TBL] [Abstract][Full Text] [Related]
6. Hydroxymethylglutaryl--CoA reductase inhibitor inhibits induction of nitric oxide synthase in 3T3--L1 preadipocytes. Dobashi K; Araki S; Kubo K; Kawagoe R; Yamamoto Y; Shirahata A Life Sci; 2008 Jan; 82(1-2):85-90. PubMed ID: 18036617 [TBL] [Abstract][Full Text] [Related]
7. Cytokine-stimulated inducible nitric oxide synthase expression in astroglia: role of Erk mitogen-activated protein kinase and NF-kappaB. Marcus JS; Karackattu SL; Fleegal MA; Sumners C Glia; 2003 Jan; 41(2):152-60. PubMed ID: 12509805 [TBL] [Abstract][Full Text] [Related]
8. Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability. Massaro M; Zampolli A; Scoditti E; Carluccio MA; Storelli C; Distante A; De Caterina R Cardiovasc Res; 2010 May; 86(2):311-20. PubMed ID: 19946014 [TBL] [Abstract][Full Text] [Related]
9. The role of Rho-associated kinase in differential regulation by statins of interleukin-1beta- and lipopolysaccharide-mediated nuclear factor kappaB activation and inducible nitric-oxide synthase gene expression in vascular smooth muscle cells. Wei CY; Huang KC; Chou YH; Hsieh PF; Lin KH; Lin WW Mol Pharmacol; 2006 Mar; 69(3):960-7. PubMed ID: 16317111 [TBL] [Abstract][Full Text] [Related]
10. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors upregulate inducible NO synthase expression and activity in vascular smooth muscle cells. Kolyada AY; Fedtsov A; Madias NE Hypertension; 2001 Nov; 38(5):1024-9. PubMed ID: 11711492 [TBL] [Abstract][Full Text] [Related]
11. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells. Jantzen F; Könemann S; Wolff B; Barth S; Staudt A; Kroemer HK; Dahm JB; Felix SB; Landsberger M J Physiol Pharmacol; 2007 Sep; 58(3):503-14. PubMed ID: 17928646 [TBL] [Abstract][Full Text] [Related]
12. Statin-induced breast cancer cell death: role of inducible nitric oxide and arginase-dependent pathways. Kotamraju S; Williams CL; Kalyanaraman B Cancer Res; 2007 Aug; 67(15):7386-94. PubMed ID: 17671209 [TBL] [Abstract][Full Text] [Related]
13. Differential inhibitory actions by glucocorticoid and aspirin on cytokine-induced nitric oxide production in vascular smooth muscle cells. Katsuyama K; Shichiri M; Kato H; Imai T; Marumo F; Hirata Y Endocrinology; 1999 May; 140(5):2183-90. PubMed ID: 10218970 [TBL] [Abstract][Full Text] [Related]
14. Cytokine-activated p42/p44 MAP kinase is involved in inducible nitric oxide synthase gene expression independent from NF-kappaB activation in vascular smooth muscle cells. Doi M; Shichiri M; Katsuyama K; Marumo F; Hirata Y Hypertens Res; 2000 Nov; 23(6):659-67. PubMed ID: 11131279 [TBL] [Abstract][Full Text] [Related]